CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award

The Canadian Cardiovascular Society, HSRLCE, and the BI-Lilly alliance created an award entitled “CCS/HSRLCE/BI-Lilly-Cardiometabolic Research Award.” This Award is intended for Canadian clinical residents (PGY 4-6), or PhDs and MDs who are within five years of their first faculty appointment at a Canadian academic institution for a research project on any topic related to cardiometabolic disease.

We received 18 submissions: 2 from Alberta, 3 from British Columbia, 1 from Nova Scotia, 8 from Ontario and 4 from Quebec.

Two finalists were selected to present their research project at a session held during the virtual CCC on October 22nd. Dr. Piché was awarded first place prize ($25,000) and Dr. Quimet was awarded second place prize ($20,000).

  1. Dr. Marie-Eve Piché “Effects of Exercise and lifestyle intervention on subclinical cardiac function in adults with metabolic syndrome: a 16-week randomized study” – University of Ottawa
  2. Dr. Mireille Ouimet “Role of Lipophagy in Macrophage Polarization” – Laval University

Congratulations to the winners!

The next competition will be in August 2021.

 

Liz ThuoCARDIOMETABOLIC RESEARCH AWARD FOR YOUNG INVESTIGATORS

HSRLCE Undergraduate Awards: HSBC Future Research Leaders Internships

The Heart & Stroke/Richard Lewar Centre of Excellence (HSRLCE, the Centre) offered two summer undergraduate awards of $4,500 to enable students to work alongside scientists in cardiovascular research laboratories associated with the Peter Munk Cardiac Centre.

The Centre’s undergraduate awards, funded by the HSBC, are intended to support our future research leaders in the initial phase of their training. The objective of these awards is to support a robust and productive research community in Toronto. These awards are made to those who demonstrate the potential for excellence through their previous academic accomplishments and the environment in which they will work.

2020 Recipients

The two 2020 awardees were:

Hifza Buhari

  • Supervisor: Dr. Husam Abdel-Qadir
  • Project: WISER – Cardiac imaging utilization and cardiovascular risk prediction during Breast Cancer chemotherapy
  • Study: Can we identify cardiac imaging tests that are more likely to yield abnormal findings or change patient care, as well as tests that have a low likelihood of actionable results?

Steven Botts

  • Supervisor: Dr. Kathryn Howe
  • Project: Blood microbiota: Novel biomarkers for the development of chronic limb threatening ischemia
  • Research Question: Do peripheral artery disease (PAD)  patients with chronic limb threatening ischemia (CLTI) show altered blood microbiota composition as compared to those with intermittent claudication?

 

Next application date: March 31, 2021

Liz Thuo2020 HSRLCE/HSBC Award Recipients

Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain

Nikolaev SI, Vetiska S, Bonilla X, Boudreau E, Jauhiainen S, Jahromi BR, Khyzha N, DiStefano P, Rhyner
AM, Kinnunen S, Kiehl TM, Pereira VM, Antonarakis SE, Krings T, Andrade H, Tung T, Valiante T, Zadeh
G, Tymianski M, Rauramaa T, Ylä-Herttuala S, Wythe JD, Frösen J, Fish JE, Radovanovic I.

N Engl J Med. 2018 Jan 18; 378:250-261 DOI: 10.1056/NEJMoa1709449

Liz ThuoSomatic Activating KRAS Mutations in Arteriovenous
Malformations of the Brain
N Engl J Med. 2018 Jan 18

CANHEART SPOR Fellowship Program

 

DESCRIPTION OF THE RESEARCH PROGRAM:

The CANHEART ‘big data’ research initiative (www.canheart.ca) is aimed at measuring and improving cardiovascular health and the quality of ambulatory cardiovascular care provided in Ontario, Canada using the population-based CANHEART cohort. The CANHEART cohort is created through the linkage of 17+ routinely collected health administrative, vital statistics, survey and laboratory databases housed at the Institute for Clinical Evaluative Sciences (https://www.ices.on.ca). The strength of this cohort lies in the large sample size, containing information on 9.8 million Ontarians age 20-105 years, and diversity of the linked databases.

Building upon the insights gained to date through the CANHEART work, we have also recently launched a new CANHEART SPOR project aimed at leveraging big data to conduct innovative cardiovascular clinical trials. We will aim to: 1) undertake a pragmatic cluster randomized registry-based clinical trial to improve lipid-management amongst intermediate-and high-risk patients residing in high-risk health regions in Ontario, and 2) develop novel algorithms for measuring clinical outcomes in clinical trials using health-related databases and compare whether they are as accurate as traditional event ascertainment methods. These projects will be undertaken by an interdisciplinary team consisting of experts in administrative health databases, implementation science, clinical trials, knowledge translation and patient engagement.

Fellows will have opportunities to support both the CANHEART and CANHEART SPOR initiative. Potential options for research projects and programs include, but are not limited to:

  • Quantitative studies examining the association between patient, community and health system factors, and the incidence of cardiovascular health outcomes.
  • Studying lipid management in the province (e.g., lipid screening, cardiovascular risk assessment, statin utilization and adherence to the Canadian Cardiovascular Society’s lipid guidelines), including knowledge translation activities and qualitative studies in these areas.
  • Working with the study team to develop novel algorithms for identifying clinical outcomes (e.g., myocardial infarction, heart failure) using health administrative data (e.g., hospitalization, emergency department), laboratory data (e.g., Ontario Laboratory Information System), and clinical registries (e.g., CorHealth cardiac procedures).
  • Development of novel methods for using ‘big data’ to conduct clinical trials.

NOTE: Fellows are encouraged to send a brief summary of their proposed research plan to the CANHEART office (tara.oneill@ices.on.ca) in advance of the deadline for a review of the relevance of their research plan to the CANHEART SPOR initiative.  Requests for reviews should be submitted to CANHEART by Friday March 30th 2018.

 ELIGIBILITY CRITERIA

  1. The program is open to both Canadian citizens and fellows from abroad who wish to undertake fellowship training at the University of Toronto or one of its affiliated institutions.
  2. The research should be conducted under the supervision of a senior investigator on the CANHEART SPOR research team. Students are encouraged to view the list of CANHEART SPOR investigators willing to supervise students and their areas of research interest. The investigator must also be a member of the Heart & Stroke/ Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE), or willing to join if you are successful in the competition. As an alternative, students may have a co-supervisor who is a member of the HSRLCE. The list of HSRLCE members can be found here.
  3. Each application is considered a joint submission by the applicant and the proposed supervisor. The research plan should be written in full by the student in consultation and in agreement with the supervisor.
  4. Applicants to the fellowship competition must have completed a PhD or MD degree or equivalent, or intend to have completed one of these degrees at the time of commencement of funding. Equivalence will be determined at the discretion of the evaluating committee. Documentation of degree completion will be required prior to the initiation of funding. If you have an MD and are pursuing a PhD, you must wait until your PhD studies are completed before applying for this award.
  5. Applicants MUST BE pursuing a research program. Clinical practice-based fellowships will NOT be supported. It must be documented with the application that a candidate with clinical interests will dedicate at least 75% of their time and effort to their research project(s).
  6. The applicant’s research project should be primarily in the area of the cardiovascular sciences. Relevance to cardiovascular science will be determined by the committee which evaluates all applications.
  7. Applicants must not have held a previous faculty appointment.
  8. Applicants should not have completed more than four years of post-doctoral training (PhD or MD) anywhere at the time of application (April 27, 2018). Interruptions in the applicant’s career, either during or subsequent to training, should be briefly described.
  9. Applicants to the HSRLCE fellowship program must have applied to a major funding agency (such as the HSFC or CIHR) for a 2018/2019 fellowship award prior to applying to the HSRLCE program, or intend to apply for an external award by the end of their first year in the fellowship program. Proof of your application to an external agency should be included with your application.
  10. If an applicant has or is awarded a fellowship from one of these agencies, the fellow becomes ineligible for an HSRLCE award.  They must accept the external award and forfeit the HSRLCE award.
  11. Individuals wishing to undertake post-PhD training with their PhD supervisor, or in the same department in which they received their doctoral training, may be eligible for a HSRLCE fellowship. However, these candidates are advised that a change of training environment is strongly encouraged, and this factor will be considered in the scoring of the candidate’s application.
  12. Limited funds may preclude the funding of all excellent applicants. The Centre reserves the right to limit the number of awards to fellows of a single investigator. In the case of multiple applications in a single calendar year from the same laboratory, the principal investigator in the laboratory must rank the applicants to indicate priority for funding. This criteria will be applied secondarily to the criteria of excellence.

TERMS AND CONDITIONS OF THE AWARD

Duration of Support:

Awards will be made for a period of twelve consecutive months. There is no limit to the number of years that an applicant may compete for an HSRLCE studentship, but the individual must re-apply each year. It is expected that candidates will show good progress in their studies to be awarded a HSRLCE studentship in successive years. Awards will commence on the later of September 1, 2018 or the start date of the awardee’s entry into his or her MSc or PhD program (not later than January 1, 2019).

Location of Tenure:

Awardees must be pursuing a research fellowship in cardiovascular science at the University of Toronto or one of its affiliated hospitals. They should be supervised by a researcher who holds research funds obtained through a recognized competitive peer review process.

Funding:

The annual stipend for studentship awards will be $25,000. Non-discretionary benefits are not included in the HSRLCE studentship and are the responsibility of the student’s supervisor. Funding for successful applicants will be provided directly through the HSRLCE or through other sources available to the supervisor (e.g., CIHR or other grants). For applicants who receive the HSRLCE fellowship award, top-up funding may also be available through their supervisors.

Evaluation Criteria:

Applications will be evaluated on the basis of the following criteria:

  1. The applicant’s academic record and perceived potential as indicated in the letters of recommendation submitted with the application
  2. The research project, including significance to the field of cardiovascular science, rigor of design, and preliminary results (if applicable)
  3. The environment in which the applicant will do their research project
  4. A minor component of the evaluation will be based on other factors that the reviewers consider relevant to the potential success of the applicant’s fellowship

The review process will consist of an in-depth review of each application by two reviewers from the review committee. The review committee will consist of individuals from the Toronto cardiovascular research community, representing a cross-section of expertise. Once the in-depth individual reviews have been completed, this committee will meet as a group to discuss and finalize the individual reviews of each of the HSRLCE fellowship applications. A consensus score will be assigned to each application. Conflict of interest rules will be observed, such that any member of the review committee who supervises, co-supervises or otherwise advises a candidate will excuse themselves from the discussion of that candidate’s application. Awards will be offered to the highest ranking applicants. A pre-set level will be established, and applications ranked below this level will be ineligible to receive awards.

Important Dates:

Applications are due on April 27, 2018 at 4:00 pm. Late or incomplete submissions will not be accepted.
Funding begins — September 2018

APPLICATION DETAILS

A complete application (hard copy and electronic) will consist of:

  1. A completed HSRLCE fellowship application form including applicant and supervisor sections; Click the link to download the 2018-2019 fellowship application-applicant section and the 2018-2019 fellowship application-supervisor section
  2. Official transcript of the applicant’s academic record (last degree obtained) – unofficial web transcripts are not acceptable
    You can have the transcripts sent directly to you and you may open the envelope to scan the transcripts for inclusion in the PDF application
  3. Up to three (3) of the applicant’s publications – (do not send preprints, proofs or manuscripts in preparation)
  4. Evidence that you have applied to external awards (e.g. HSFC, CIHR)
    This can include either the signature page of your HSFC, CIHR, etc application form, or a screenshot of the confirmation page of your HSFC, CIHR, etc application. For applicants who will apply for an external award within the first year of their fellowship, continued funding is contingent upon providing evidence of this application being sent to the HSRLCE.
  5. Printed version of your Canadian Common CV module, in Academic CV- CIHR format https://ccv-cvc.ca/
  6. Proof of Canadian licensure to practice medicine (if applicable)
  7. Statement from department head that at least 75% of the applicant’s time will be reserved for research activities (applicable to clinical fellows only)

All the above components of the application should be combined into one PDF file.

  1. Confidential letters of recommendation should be forwarded by the referees, in PDF format, directly to HSRLCE at hsrl.centre@utoronto.ca; The referee assessment form should be filled out by two different individuals. If the candidate has completed a PhD, it is recommended that the applicant’s PhD advisor is one of the references; Click the link to download the 2018-2019 fellowship application-referee section. 

General instructions for submitting an application:

  1. Do not fold or place any part of the applications in folders or envelopes, except the entire completed application package, as required for delivery.
  2. Completion of the Canadian Common CV module, Academic CV- CIHR format, (https://ccv-cvc.ca/) requires obtaining a password -which may take some time so plan ahead. Only those pages relevant to the candidate need be submitted. DO include relevant attachments, such as activities/contributions, interruptions/delays, patents and copyrights, and publications, if applicable.
  3. The section marked Progress Report should be completed by all applicants. If the applicant is entering their fellowship training in the current year, then the Progress Report should consist of the progress the applicant believes he or she has made towards establishing his or her cardiovascular research career to-date. Those who are seeking renewal of an HSRLCE fellowship should focus on the progress made in their fellowship tenure.

Font, spacing and margin restrictions:
All attached pages must conform to the following format restrictions:
– A one inch margin should surround the text on all attached pages.
– Text must be no smaller than twelve point, or ten characters per inch.
– No condensed formatting is allowed.

Applications should be submitted to:

Liz Thuo
Business and Communications Manager
Heart & Stroke/Richard Lewar Centre of Excellence
University of Toronto, David Naylor Building
6 Queens Park Crescent West, Room 303
Toronto, ON  M5S 3H2
Phone: (416) 978-2351
Email: hsrl.centre@utoronto.ca

In addition, a PDF of this application and a letter of support from the CANHEART SPOR investigator(s) willing to supervise you, must also be submitted to the CANHEART office at: tara.oneill@ices.on.ca

 

Liz ThuoCANHEART/SPOR Fellowship Program

Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry.

Patel A, Goodman SG, Yan AT, Alexander KP, Wong CL, Cheema AN, Udell JA, Kaul P, D’Souza M, Hyun K, Adams M, Weaver J, Chew DP, Brieger D, Bagai A.

J Am Heart Assoc. 2018 Sep 18;7(18):e009859. doi: 10.1161/JAHA.118.009859.

Liz ThuoFrailty and Outcomes After Myocardial Infarction:
Insights From the CONCORDANCE Registry
J Am Heart Assoc. 2018 Sep 18

 

 Logored-01-05 

FACULTY OF MEDICINE – UNIVERSITY OF TORONTO

DISTINGUISHED VISITING PROFESSOR

Dr. Peter Backx

Professor, Departments of Physiology and Medicine, University of Toronto

Director, Transgenic Physiology Laboratory

“Links between endurance exercise and atrial fibrillation: what every sports buff should know”

DATE/TIME:

December 7th, 2015 from 4:30pm – 5:30pm

 

LOCATION:

MaRS Collaboration Centre, 101 College Street Main floor Room CR-2 (street Level)

 

Reception to follow lecture – 5:30pm – 6:00pm

Liz ThuoDVP Lecture:Dr. Peter Backx

December 7th 4:30pm

Reception to Honor Dr. Backx to follow

HSF_ClinicalUpdate_F15_HomePage_730x250px_v4

46th Heart&Stroke Clinical Update –
TOP 10 DEVELOPMENTS THAT COULD CHANGE YOUR PRACTICE

EARLY BIRD ENDING OCT. 31! Register now to save up to $100.

Event was SOLD OUT LAST YEAR – register early to avoid disappointment.

December 4-5, 2015
Pre-conference Workshops December 3, 2015
Hilton Toronto Downtown

Don’t miss your chance to attend this unparalleled knowledge exchange event to:

• Join the discussion in new medications: antiplatelet therapy, anticoagulants and new therapies in lipids and hypertension.
• Learn more about starting and adjusting insulin, managing heart failures, and the investigation and management of pre-syncope cases.
• Attend practical workshops in TIA, secondary stroke prevention, bariatric surgery, ECG, echo and heart murmurs etc.
• Find out more about the latest gadgets and devices in your patients’ body (that may surprise you).

Accreditation
This continuing education event was held under the auspices of Continuing Professional Development, Faculty of Medicine, University of Toronto and Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research.

Royal College of Physicians and Surgeons of Canada – Section 1:
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto up to a maximum of 12 hours.

College of Family Physicians of Canada – Mainpro M1:
This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited by Continuing Professional Development, Faculty of Medicine, University of Toronto, for up to 12 Mainpro-M1 credits.

Get the most out of your time when you are with the Clinical Update! Join other accredited pre-conference workshops (Dec. 3) such as:
THE HEALTH PROMOTION 6 PACK (HP6): MOTIVATING PATIENTS TO CHANGE UNHEALTHY BEHAVIOURS IN CLINICAL PRACTICE offered by CAMH
and
HYPERTENSION MANAGEMENT TRAIN-THE–TRAINER WORKSHOP offered by Hypertension Canada

For more information and registration, please visit the Pre-Conference Workshops section.

Register today at Heartandstroke.ca/clinicalupdate

Liz ThuoHeart and Stroke Clinical Updates

December 4-5th, 2015

Please join us for a Distinguished Visiting Professor Series Lecture by Dr. Darren McGuire, Professor of Internal Medicine, Director of the Cardiology Clinical Trials unit, and Director of the Parkland Hospital and Health System Outpatient Cardiology clinics, UT Southwestern. His talk will be held on Monday, October 19th 4:30pm in the Health Sciences Building Auditorium 6th floor, 155 College Street.

Date: Monday October 19, 2015

Time: 4:30-5:30 pm (followed by reception – refreshments will be served)

Speaker:
Darren McGuire, MD
Professor of Internal Medicine, Director of the Cardiology Clinical Trials unit, and Director of the Parkland Hospital and Health System Outpatient Cardiology clinics, UT Southwestern

 Talk Title:
“To be determined”

Location:
Health Sciences Building Auditorium 6th floor, 155 College Street.

Liz ThuoDVP Lecture: Dr. Darren McGuire

October 19th 4:30pm

Please join us for a Distinguished Visiting Professor Series Lecture by Dr. Robin Choudhury, Professor of Cardiovascular Medicine, Clinical Director Oxford Acute Vascular Imaging Centre Radcliffe Department of Medicine, University of Oxford. His talk will be held on Monday, September 21, 2-15 4:30pm in the Health Sciences Building Auditorium 6th floor, 155 College Street.

Date: Monday September 21, 2015

Time: 4:30-5:30 pm (followed by reception – refreshments will be served)

Speaker:
Robin Choudhury FRCP
Professor of Cardiovascular Medicine, Clinical Director Oxford Acute Vascular Imaging Centre Radcliffe Department of Medicine, University of Oxford

 Talk Title:
“Characterisation of the monocyte response in acute myocardial infarction – insights from transcriptomic studies in mice and men”

Location:
Health Sciences Building Auditorium 6th floor, 155 College Street.

Liz ThuoDVP Lecture: Dr. Robin Choudhury

September 21, 2015 4:30pm

9th Annual

LANDMARK

LECTURE SERIES

Featuring:

Douglas Zipes, MD

Distinguished Professor, Professor Emeritus of Medicine,
Pharmacology and Toxicology,
Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology,
Indiana University School of Medicine

Topic:
BIRTH AND MATURATION OF CARDIAC ELECTROPHYSIOLOGY AS A SPECIALITY

Monday, October 5, 2015

6:00 p.m. – 8:30 p.m.

The Allan Waters Family Auditorium
Li Ka Shing Knowledge Institute of St. Michael’s Hospital
209 Victoria Street, Toronto, ON

6:00 pm – 7:00 pm – Registration and Dinner Reception
7:00 pm – 8:30 pm – Landmark Lecture

Register at:

https://www.eply.com/landmarklecture

Landmark 2015 Invitation

Liz ThuoLandmark Lecture Series- Dr. Douglas Zipes

October 5, 2015 6:00pm

Please join us for a Distinguished Visiting Professor Series Lecture by Dr. André La Gerche, Head of Sports Cardiology at the Baker IDI Heart and Diabetes Institute Melbourne. His talk, will be held on Tuesday, May 19th 5pm in the Li Ka Shing Auditorium, 209 Victoria Street.

Date: Tuesday May 19th, 2015

Time: 4:30-5:30 pm (followed by reception – refreshments will be served)

Speaker:
André La Gerche, MBBS, PhD
Head of Sports Cardiology at the Baker IDI Heart and Diabetes Institute Melbourne

 Talk Title:
“Identifying (the few) endurance athletes at risk of arrythmias”

Location:
Li Ka Shing Auditorium, 209 Victoria Street (auditorium is one floor up from the main street level doors)

Liz ThuoDVP Lecture: Dr. Andre La Gerche

May 19th, 4:30pm

Please join us for a Distinguished Visiting Professor Series Lecture by Dr. Eduardo Marbán, Director, Cedars-Sinai Heart Institute. His talk, will be held on Monday, May 11th 5pm in the Li Ka Shing Auditorium, 209 Victoria Street.

Date: Monday May 11th, 2015

Time: 5:00-6:00 pm (followed by reception – refreshments will be served)

Speaker:
Eduardo Marbán, M.D., PhD.
Director, Cedars-Sinai Heart Institute

 Talk Title:
“Therapeutic regeneration of the “irreversibly” injured human heart”

Location:
Li Ka Shing Auditorium, 209 Victoria Street (auditorium is one floor up from the main street level doors)

Liz ThuoDVP Lecture: Dr. Eduardo Marbán

May 11, 5pm

The 2015 HSRLCE Michael J. Sole Annual Cardiovascular Scientific Day will beheld on Thursday April 16, 2015 at the Toronto Reference Library. The theme is VASCULAR MEDICINE AND THERAPEUTICS. See the attached draft program. 

2015 ACvSD Draft Program

Deadline for Online registration is Monday April 13th

Deadline for Abstract Submission is Monday April 6th 2015 ACvSD Poster Abstract Form

 

 

Liz ThuoMichael J. Sole Scientific Day

Thursday April 16, 2015

Please join us for a Distinguished Visiting Professor Series Lecture by Dr. Garret FitzGerald, McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania, Chair of the Department of Pharmacology and Director of the Institute for Translational Medicine and Therapeutics. His talk, will be held on Thursday, March 26th from 5pm at the Li Ka Shing Auditorium, 209 Victoria Street.

Date: Thursday, March 26th, 2015

Time: 5:00-6:00 pm (followed by reception – refreshments will be served)

Speaker:
Garret FitzGerald, M.D.
McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania, Chair of the Department of Pharmacology and Director of the Institute for Translational Medicine and Therapeutics

 Talk Title:
Adventures with Peripheral Clocks

Location:
Li Ka Shing Auditorium, 209 Victoria Street

 

Liz ThuoDVP LECTURE: DR. Garret FitzGerald

Thursday March 26th, 5:00PM

 

Please join us for our next Distinguished Visiting Professor Series Lecture by Dr. Jacques Genest of McGill University. His talk, “Systems and Molecular Approaches to Severe Hyperlipidemias (SMASH)” will be held on Monday, March 2nd from 5-6 pm at the Tanz Neuroscience Building, Imperial Oil Lecture Theatre, 6 Queens Park West. See HSRLCE DVP- Jacques Genest for more details or see below.

Date:
Monday, March 2nd, 2015

Time:
5:00 pm – 6:00 pm (followed by reception – refreshments will be served)

Speaker:
Jacques Genest, M.D.
Professor, Faculty of Medicine; Novartis Chair in Medicine, McGill University

 Talk Title:
“Systems and Molecular Approaches to Severe Hyperlipidemias (SMASH)”

Location:
Tanz Neuroscience Building, Imperial Oil Lecture Theatre, 6 Queens Park West

(Located on the NW corner of College and University behind the Leslie Dan Pharmacy Building, please use the rear entrance at the west corner of the building, the room is located on the lower level)

 

Liz ThuoDVP LECTURE: DR. Jacques Genest

Monday March 2nd, 5-6 PM

Please join us for our next Distinguished Visiting Professor Series Lecture by Dr. Joseph Hill of University of Texas Southwestern Medical Center. His talk, Cardioprotection: Tale of Two Mechanisms” will be held on Monday, January 26th from 5-6 pm at the Fitzgerald Building Lecture Theatre, 150 College Street, Room 103.  Click here for details or see below.

Date:
Monday, January 26, 2015

Time:
5:00 pm – 6:00 pm (followed by reception – refreshments will be served)

Speaker:
Joseph A. Hill, M.D., Ph.D.
Professor of Internal Medicine and Molecular Biology and Chief, Division of Cardiology at the University of Texas Southwestern Medical Center

 Talk Title:
“Cardioprotection: Tale of Two Mechanisms”

Location:
Fitzgerald Building Lecture Theatre
150 College Street, Room 103
University of Toronto

Liz ThuoDVP SERIES LECTURE: DR. JOSEPH HILL – MONDAY JAN. 26, 5-6 PM

Every December the HSRLCE showcases one of its own for its Distinguished Professor Lecture Series. This year we have the pleasure of highlighting Dr. Vivek Rao, Professor of Surgery at the University of Toronto, Chief of Cardiovascular Surgery, and Munk Professor in Advanced Cardiac Therapeutics at Peter Munk Cardiac Centre.

Please join us on Monday, December 1st from 5-6 pm for Dr. Rao’s lecture: “Translational Concepts in Regenerative Medicine: Pitfalls with Innovation”. The talk will be held at the Imperial Oil Lecture Theatre located in the basement level of the Tanz Neuroscience Building, University of Toronto. Click here for details or see below.

Date:
Monday, December 1, 2014

Time:
5:00 pm – 6:00 pm (followed by reception – refreshments will be served)

Speaker:
Dr. Vivek Rao, MD, PhD, FRCS(C), F.A.H.A
Chief of Cardiovascular Surgery, Munk Professor in Advanced Cardiac Therapeutics at Peter Munk Cardiac Centre, and Professor of Surgery at the University of Toronto

Talk Title:
Translational Concepts in Regenerative Medicine: Pitfalls with Innovation”

Objectives:
1. To understand the role of the Extracellular Matrix (ECM) in myocardial regeneration
2. To understand the clinical application of ECM technology
3. To appreciate the shortcomings of ECM therapy in clinical practice

Location:
Tanz Neuroscience Building
Imperial Oil Lecture Theatre (Room 6&7)
6 Queen’s Park Crescent West, University of Toronto

 

 

 

     

 

 

Liz ThuoDVP Series Lecture: Dr. Vivek Rao – Monday Dec. 1, 5-6 pm

Dr. Stefan Anker, an international heart failure expert, will be in Toronto on November 12 (on his way to AHA) and has offered to give a special rounds on his research.
Dr. Anker is Professor of Innovative Clinical Trials (Cardiology & Cachexia Research) at University Medical Center Göttingen (Germany). He has authored more than 500 original papers, reviews, and editorials that are well cited. He is a member of multiple international clinical trial steering committees.

Date: Wednesday, November 12
Time: 4 to 5 pm
Talk Title: Co-morbidities in Heart Failure: Update on Cachexia & Iron Deficiency
Venue:
Toronto General Hospital
Bayer Conference Room (12EC-315)
Eaton Wing, 12th Floor, Room 315
200 Elizabeth Street

HSRLCE DVP – Stefan Anker – PDF Info

wp_adminHSRLCE Special DVP Rounds – Stefan Anker – Wed. Nov 12, 4-5pm

Welcome to the HSRLCE’s newly re-launched website.

Please peruse at your leisure. We welcome researchers to our membership.

– Michael E. Farkouh, MD
Director, Heart & Stroke/Richard Lewar Centres of Excellence

wp_adminWelcome to the HSRLCE’s newly re-launched website.

The Canadian Critical Care Forum (http://www.criticalcarecanada.com) is a 3 day international conference that happens in Toronto every year. This year the meeting will be from Oct. 29 – Nov. 1, 2014. This is the largest Critical Care related meeting in Canada. The CCCF is a forum to showcase cutting edge research and share new ideas with researchers and clinicians interested in the care of critically ill patients. This year we are celebrating our 10th anniversary and we are looking to expand our scientific session by reaching out to scientists and their trainees all over Canada and abroad with a research interest in Critical Care or critical care related topics (e.g. pediatric ICU, acute myocardial failure, shock, sepsis, transplant, respiratory failure, acute kidney injury, acute liver failure, traumatic brain injury, resuscitation, bioimaging, etc.).

Link for Call For Abstracts page: http://www.criticalcarecanada.com/call-abstracts/

Early Submission deadline: August 15, 2014
Early Acceptance/ rejection Notices: September 1, 2014
Late Breaking Submission: September 12, 2014
Acceptance/ rejection Notices: September 30, 2014

Link for online submission site: http://precis2.preciscentral.com/Link.aspx?ID=3061F2C98DA0A936412D534299D1E1E3
– See more at: http://www.hsrlce.com/newsannouncements/14-07-02/Canadian_Critical_Care_Forum-_Oct_29_%e2%80%93_Nov_1_2014.aspx#sthash.EoqvXmuR.dpuf

wp_adminCanadian Critical Care Forum – Oct. 29 – Nov. 1, 2014